Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Jun 15, 2023; 15(6): 1086-1095
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1086
Table 1 General clinical characteristics of the subjects
Characteristics
CRC (training)
HC (training)
CRC (validation)
HC (validation)
Number10119562100
Age, yr
    Mean58535755
    Range29-8133-5733-7434-67
Sex
    Male601163764
    Female41792536
TNM stage
T11111
T22721
T3447
T41923
Table 2 Comparison of the four markers between the healthy control group and colorectal cancer group
Indicator
HC (n = 195)
CRC (n = 101)
F
Sig
P value
NDUFB71.54 (0.94, 2.31)2.10 (1.29, 3.08)0.150.700.60
CAMK1D9.71 (6.38, 18.25)70.39 (35.26, 155.57)34.24< 0.01< 0.01
PIK3CD297.11 (232.76, 374.69)333.22 (259.40, 417.90)10.47< 0.010.03
PSEN25.48 (4.04, 7.21)8.69 (6.00, 11.67)5.890.02< 0.01
Table 3 Evaluation of the diagnostic value of three markers exhibiting statically significant differences between the healthy control group and colorectal cancer group
IndicatorAUCSDP value95%CI
Lower
Upper
CAMK1D0.9350.015< 0.0010.9070.964
PSEN20.7400.031< 0.0010.6780.801
PIK3CD0.5820.0360.0210.5110.653
Table 4 Univariate and multivariate logistic regression of CAMK1D and PSEN2
IndicatorBSEWalsP valueExp (B)95%CI
Lower
Upper
CAMK1D0.5600.13716.781< 0.0011.7511.3392.289
PIK3CD0.0710.01141.382< 0.0011.0741.0511.097
Table 5 Multivariate logistic regression of CAMK1D and PSEN2
IndicatorBSEWalsP valueExp (B)95%CI
Lower
Upper
CAMK1D0.1250.03910.4000.0011.1331.0501.222
PIK3CD-0.0020.0040.2080.6480.9980.9901.006